AzTrials
AzTrials

ICLNCT07146737

Predictive Performance of a Generative Model for Corneal Tomography After ICL Implantation

An observational study of ICL and Vault, run by Second Affiliated Hospital of Nanchang University at 1 site in China.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

To evaluate the efficacy of a corneal tomography Imaging model in predicting postoperative vault based on preoperative corneal topography in Implantable Collamer Lens (ICL) surgery. Read more about this study

Who is it for?
Ages 18 to 45 years
Conditions the study is for
ICL, Vault, Deep Learning
What is being tested?
Corneal tomography generation model after ICL surgery
How many people
818 participants
Where
1 siteChina
Study dates
1 Jul 2025to 31 Dec 2028
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • No healthy volunteers
  • Adult

Study population: Patients from clinics in different eye centers across China. Each subject must with complete surgical video recording and medical records.

Inclusion Criteria:(1) stable myopia (≤0.50D/year change for 2 years), (2) ACD ≥2.80mm, (3) intact corneal endothelium (≥2000 cells/mm²), and (4) no confounding ocular/systemic conditions.

Exclusion Criteria:(1) glaucoma-spectrum disorders or retinal vasculopathies, (2) prior corneal/intraocular surgery, (3) compromised corneal endothelium, (4) uncontrolled systemic diseases, and (5) pregnancy/lactation.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

China1 site, 1 recruiting
  • The Second Affiliated Hospital of Nanchang University

    Nanchang, Jiangxi

    Fu Gui, doctor, +8613879101919, 564436578@qq.com

    Jian Xiong, doctor, +8618170906556, 894040417@qq.com

    Recruiting

Other trials in China

About this study

Official title: Predictive Performance of a Generative Model for Corneal Tomography After Implantable Collamer Lens Implantation

To evaluate the efficacy of a corneal tomography Imaging model in predicting postoperative vault based on preoperative corneal topography in Implantable Collamer Lens (ICL) surgery.

Read the detailed description

Accurate vault prediction is crucial for Implantable Collamer Lens (ICL) surgery safety and efficacy. Current methods using preoperative biometrics and regression formulas show limited accuracy due to parameter variability and incomplete utilization of corneal topography data. To address this, we developed a deep learning model that predicts postoperative vault while generating anterior chamber morphology images from preoperative data, enabling personalized surgical planning.

Being tested
Corneal tomography generation model after ICL surgery
Keywords
Implantable Collamer Lens (ICL) implantation surgery, Corneal tomography, vault, Artificial Intelligence, Deep Learning
Medical subject headings
T-Lymphocytopenia, Idiopathic CD4-Positive

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Corneal tomography generation model after ICL surgeryDiagnostic test

    The ICL procedures collected would be assessed by the corneal tomography generation model. The performance of the model would be assessed, including accuracy,AUC, sensitivity and specificity.

Study groups in NCT07146737
Study groupRoleWhat they receive
Eyes with ICL surgeriesEyes with ICL surgeries which were performed by surgeons with experiences.
Receives: Diagnostic Test: Corneal tomography generation model after ICL surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. AUROC of convolutional neural network in predicting vault after ICL surgery

    The area under the receiver operating characteristic of convolutional neural network in predicting vault after ICL surgery

    Measured: Day 7

Secondary outcomes (1)
  1. Sensitivity and specificity of convolutional neural network in predicting Vault after ICL implantation

    Sensitivity and specificity of convolutional neural network in predicting Vault after ICL implantation

    Measured: Day 7

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Aug 2025
  2. Study start1 Jul 2025
  3. Primary completion3 Jul 2025
  4. Study completion31 Dec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
818 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07146737
Sponsor's protocol ID
[2025] NO.(86)
Status last verified
Aug 2025
First submitted
21 Aug 2025
Last updated
28 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of ICL and Vault, run by Second Affiliated Hospital of Nanchang University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 28 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Fu F Gui (+8613879101919, 564436578@qq.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

AUROC of convolutional neural network in predicting vault after ICL surgery (time frame: Day 7). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in